Chemed Return on Equity

Chemed (CHE) currently reports a ROE of 33.11%. That is above the Healthcare sector average of 21.67%. Use the charts on this page to explore Chemed's ROE history and peer comparisons.

Chemed's ROE of 33.11% is higher than the Healthcare sector average of 21.67%. That is roughly 52.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Chemed's current 33.11% should be judged against Healthcare norms (sector average: 21.67%) and against CHE's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 33.11%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.67%. From there, open related valuation or income-statement pages for Chemed, and consider following CHE for alerts when major investors trade the stock.

Chemed is classified in the Healthcare sector. On ROE, it currently shows 33.11% versus a sector average near 21.67%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CHE with unrelated industries.